Search results

Combined users meeting highlights how ANSTO expertise and infrastructure can assist research community.

X-ray crystallography at the Australian Synchrotron contributed to major research findings.

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.

The Australian Centre for Neutron Scattering maintains a sample environment service for the instruments. It comprises a range of sample environments, two sample environment laboratories and four sample preparation laboratories.

ANSTO’s vision is to deliver excellence in innovation, insight and discovery through our people, partnerships, nuclear expertise and landmark infrastructure. We are committed to investing in our people to achieve this vision.

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

Southern Cross researcher Dr Alana Gall, who recently became an ANSTO research Fellow, has been awarded more than $640,000 to lead a research program focused on First Peoples' Cultural Medicines (also called bush medicine) in Australian healthcare.

Dr Richard Garrett featured on an ABC National program that highlighted how far we are from a future with nuclear fusion energy. Image: Jamison Daniel, Oak Ridge Leadership Computing Facility

Nuclear science and technology award recipients to deliver Distinguished Lectures at ANSTO.

Environmental Scientist Amy Macintosh is researching the impact of the petroleum industry on Australian marine life.

Lutetium-177 used for advanced prostate cancer